DCP
WST icon

Durable Capital Partners’s West Pharmaceutical WST Stock Holding History

Durable Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,172,583
Closed -$308M – 53
2025
Q3 		$308M Buy
1,172,583
+131,935
+13% +$32.1M 2.28% 18
2025
Q2 		$228M Sell
1,040,648
-532,471
-34% -$114M 1.72% 25
2025
Q1 		$352M Buy
1,573,119
+935,721
+147% +$258M 3.15% 13
2024
Q4 		$209M Sell
637,398
-448,521
-41% -$141M 1.7% 23
2024
Q3 		$326M Buy
1,085,919
+45,395
+4% +$13.9M 2.38% 17
2024
Q2 		$343M Buy
1,040,524
+9,471
+0.9% +$3.35M 2.81% 12
2024
Q1 		$408M Sell
1,031,053
-107,677
-9% -$39.8M 3.16% 10
2023
Q4 		$401M Sell
1,138,730
-63,339
-5% -$22.4M 3.17% 12
2023
Q3 		$451M Sell
1,202,069
-76,506
-6% -$29.6M 4.12% 8
2023
Q2 		$489M Buy
1,278,575
+36,757
+3% +$13.1M 4.29% 6
2023
Q1 		$430M Buy
1,241,818
+128,134
+12% +$37.4M 4.04% 7
2022
Q4 		$262M Sell
1,113,684
-65,763
-6% -$15.6M 2.72% 15
2022
Q3 		$290M Buy
1,179,447
+185,411
+19% +$56.5M 3.19% 10
2022
Q2 		$301M Buy
994,036
+245,705
+33% +$80M 3.45% 9
2022
Q1 		$307M Sell
748,331
-110,879
-13% -$43.4M 2.7% 11
2021
Q4 		$403M Hold
859,210
– – 3.15% 10
2021
Q3 		$365M Sell
859,210
-92,053
-10% -$38.8M 2.76% 12
2021
Q2 		$342M Sell
951,263
-17,362
-2% -$5.74M 2.52% 15
2021
Q1 		$273M Hold
968,625
– – 2.31% 17
2020
Q4 		$274M Sell
968,625
-137,493
-12% -$38.6M 2.44% 17
2020
Q3 		$304M Sell
1,106,118
-135,073
-11% -$35.7M 3.35% 8
2020
Q2 		$282M Buy
1,241,191
+298,370
+32% +$58.6M 3.51% 6
2020
Q1 		$144M Buy
+942,821
New +$145M 2.92% 4

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Durable Capital Partners's WST Position: Q4 2025 in Review

Durable Capital Partners sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 1,172,583 shares — an estimated $308M sold.

Durable Capital Partners first reported a position in WST in Q1 2020 and held it in 23 quarters. The position peaked at $489M in Q2 2023. 802 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Durable Capital Partners reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Durable Capital Partners sold 1,172,583 West Pharmaceutical shares in Q4 2025, an estimated $308M.
  • Durable Capital Partners first reported a position in West Pharmaceutical in Q1 2020 and held it in 23 quarters.
  • Durable Capital Partners's West Pharmaceutical position peaked at $489M in Q2 2023.
  • 802 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Durable Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.